Robert Hill
Family Medicine · Salt Lake City, UTNPI 1770521643
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 9.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $745 and has fallen 61.7% since, to $286 in 2021.
Across 107 payments — averaging $15.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$155
- Boehringer Ingelheim$154
- Sanofi-aventis U.S. LLC$128
- Pfizer$115
- Novo Nordisk$113
- Amarin Pharma, Inc.$106
- plus $843 from 24 others
What the payments were for
- Food & beverage$1,606100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $155 |
| Boehringer Ingelheim | 9 | $154 |
| Sanofi-aventis U.S. LLC | 9 | $128 |
| Pfizer | 8 | $115 |
| Novo Nordisk | 8 | $113 |
| Amarin Pharma, Inc. | 6 | $106 |
| Amgen | 6 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $88 |
| Merck | 6 | $78 |
| AbbVie(2 entities) | 4 | $76 |
| Boston Scientific | 5 | $74 |
| Lilly USA, LLC | 3 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| Gilead | 2 | $40 |
| Upsher-smith Laboratories LLC | 2 | $34 |
| Johnson & Johnson | 2 | $34 |
| Sanofi Pasteur Inc. | 2 | $30 |
| GSK | 2 | $28 |
| Biohaven Pharmaceuticals, Inc. | 1 | $26 |
| Kowa Pharmaceuticals America, Inc. | 2 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Novartis | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
| Abbott | 1 | $13 |
| Antares Pharma, Inc. | 1 | $12 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
| Biodelivery Sciences International, Inc. | 1 | $11 |
How this compares
$1,613 in reported general payments places this provider in the 65th percentile of 928 family medicine providers in Utah.
Other family medicine in Salt Lake City
- Mark CacciamaniSalt Lake City$43K
- Kirk OdonnellSalt Lake City$23K
- Jared ProbstSalt Lake City$15K
- Derek MuseSalt Lake City$14K
- Kristen RomoSalt Lake City$13K
- Julie DaySalt Lake City$11K
- Mark JohnsonSalt Lake City$8K
- Stephen ColemanSalt Lake City$8K
- David LarsenSalt Lake City$8K
- Michael CobbleSandy$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.